Semin intervent Radiol 2012; 29(01): 029-035
DOI: 10.1055/s-0032-1302449
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Inferior Vena Cava Filters for Primary Prophylaxis: When Are They Indicated?

Eric Wehrenberg-Klee
1   Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts
,
S. William Stavropoulos
2   Radiology, Division of Interventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. April 2012 (online)

Abstract

Over the past several years there has been a rapid increase in the number of inferior vena cava (IVC) filters placed for primary thromboprophylaxis. Increased use has occurred in settings where other methods of thromboprophylaxis are viewed to be inadequate, technically challenging, or that place patients at an unacceptably high bleeding risk. These clinical services include trauma, bariatric surgery, neurosurgery, cancer, intensive care unit populations, and patients with a relative contraindication to anticoagulation. We review the studies to date addressing filter placement for these indications. Although preliminary data are promising, the patient populations most likely to benefit from prophylactic IVC filter placement have not been well defined, and randomized studies demonstrating efficacy have not been conducted. Moving forward, it will be critical to accomplish these two tasks if IVC filters are to continue to have a role in primary thromboprophylaxis.

 
  • References

  • 1 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (6) 585-593
  • 2 Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 2007; 356 (14) 1438-1444
  • 3 Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 2004; 164 (14) 1541-1545
  • 4 Duszak Jr R, Parker L, Levin DC, Rao VM. Placement and removal of inferior vena cava filters: national trends in the medicare population. J Am Coll Radiol 2011; 8 (7) 483-489
  • 5 Decousus H, Leizorovicz A, Parent F , et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338 (7) 409-415
  • 6 O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J Trauma 1990; 30 (6) 748-750
  • 7 Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331 (24) 1601-1606
  • 8 Smoot RL, Koch CA, Heller SF , et al. Inferior vena cava filters in trauma patients: efficacy, morbidity, and retrievability. J Trauma 2010; 68 (4) 899-903
  • 9 Rosenthal D, Wellons ED, Lai KM, Bikk A, Henderson VJ. Retrievable inferior vena cava filters: initial clinical results. Ann Vasc Surg 2006; 20 (1) 157-165
  • 10 Allen TL, Carter JL, Morris BJ, Harker CP, Stevens MH. Retrievable vena cava filters in trauma patients for high-risk prophylaxis and prevention of pulmonary embolism. Am J Surg 2005; 189 (6) 656-661
  • 11 Meier C, Keller IS, Pfiffner R, Labler L, Trentz O, Pfammatter T. Early experience with the retrievable OptEase vena cava filter in high-risk trauma patients. Eur J Vasc Endovasc Surg 2006; 32 (5) 589-595
  • 12 Johnson III ON, Gillespie DL, Aidinian G, White PW, Adams E, Fox CJ. The use of retrievable inferior vena cava filters in severely injured military trauma patients. J Vasc Surg 2009; 49 (2) 410-416 ; discussion 416
  • 13 Gonzalez RP, Cohen M, Bosarge P, Ryan J, Rodning C. Prophylactic inferior vena cava filter insertion for trauma: intensive care unit versus operating room. Am Surg 2006; 72 (3) 213-216
  • 14 Karmy-Jones R, Jurkovich GJ, Velmahos GC , et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J Trauma 2007; 62 (1) 17-24 ; discussion 24–25
  • 15 McMurtry AL, Owings JT, Anderson JT, Battistella FD, Gosselin R. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. J Am Coll Surg 1999; 189 (3) 314-320
  • 16 Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma 2002; 53 (1) 142-164
  • 17 Antevil JL, Sise MJ, Sack DI , et al. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale. J Trauma 2006; 60 (1) 35-40
  • 18 Cherry RA, Nichols PA, Snavely TM, David MT, Lynch FC. Prophylactic inferior vena cava filters: do they make a difference in trauma patients?. J Trauma 2008; 65 (3) 544-548
  • 19 Singh P, Lai HM, Lerner RG, Chugh T, Aronow WS. Guidelines and the use of inferior vena cava filters: a review of an institutional experience. J Thromb Haemost 2009; 7 (1) 65-71
  • 20 Cuschieri J, Freeman B, O'Keefe G , et al; Inflammation and the Host Response to Injury Collaborative Research Program. Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient. J Trauma 2008; 65 (4) 944-950
  • 21 Geerts WH, Bergqvist D, Pineo GF , et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, Suppl) 381S-453S
  • 22 Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 2003; 13 (6) 819-825
  • 23 Carmody BJ, Sugerman HJ, Kellum JM , et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience. J Am Coll Surg 2006; 203 (6) 831-837
  • 24 Kaboli P, Henderson MC, White RH. DVT prophylaxis and anticoagulation in the surgical patient. Med Clin North Am 2003; 87 (1) 77-110 , viii
  • 25 Eriksson S, Backman L, Ljungström KG. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg 1997; 7 (4) 332-335 ; discussion 336
  • 26 Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med 2002; 126 (9) 1091-1095
  • 27 Rocha AT, de Vasconcellos AG, da Luz Neto ER, Araújo DM, Alves ES, Lopes AA. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg 2006; 16 (12) 1645-1655
  • 28 Frezza EE, Chiriva-Internati M. Venous thromboembolism in morbid obesity and trauma. A review of literature. Minerva Chir 2005; 60 (5) 391-399
  • 29 Frezza EE, Wachtel MS. A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring) 2006; 14 (11) 1961-1965
  • 30 Gargiulo III NJ, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg 2006; 44 (6) 1301-1305
  • 31 Overby DW, Kohn GP, Cahan MA , et al. Risk-group targeted inferior vena cava filter placement in gastric bypass patients. Obes Surg 2009; 19 (4) 451-455
  • 32 Birkmeyer NJ, Share D, Baser O , et al; Michigan Bariatric Surgery Collaborative. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg 2010; 252 (2) 313-318
  • 33 Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011; 7 (2) 181-188
  • 34 ASMBS Position Statement on Prophylactic Measures to Reduce the Risk of Venous Thromboembolism in Bariatric Surgery Patients. http://www.asbs.org/Newsite07/resources/vte_statement.pdt . Accessed July 15, 2011
  • 35 Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 1994; 34 (2) 280-296 ; discussion 296
  • 36 Dearborn JT, Hu SS, Tribus CB, Bradford DS. Thromboembolic complications after major thoracolumbar spine surgery. Spine 1999; 24 (14) 1471-1476
  • 37 Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998; 43 (5) 1074-1081
  • 38 Fukamachi A, Koizumi H, Nagaseki Y, Nukui H. Postoperative extradural hematomas: computed tomographic survey of 1105 intracranial operations. Neurosurgery 1986; 19 (4) 589-593
  • 39 Rosner MK, Kuklo TR, Tawk R, Moquin R, Ondra SL. Prophylactic placement of an inferior vena cava filter in high-risk patients undergoing spinal reconstruction. Neurosurg Focus 2004; 17 (4) E6
  • 40 Leon L, Rodriguez H, Tawk RG, Ondra SL, Labropoulos N, Morasch MD. The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vasc Surg 2005; 19 (3) 442-447
  • 41 Ozturk C, Ganiyusufoglu K, Alanay A, Aydogan M, Onat L, Hamzaoglu A. Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery. Spine 2010; 35 (20) 1893-1896
  • 42 Glotzbecker MP, Bono CM, Harris MB, Brick G, Heary RF, Wood KB. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery. Spine 2008; 33 (26) 2915-2921
  • 43 Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009; 27 (29) 4839-4847
  • 44 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293 (6) 715-722
  • 45 Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 2008; 300 (19) 2277-2285
  • 46 Lee AY, Levine MN, Baker RI , et al; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349 (2) 146-153
  • 47 Prandoni P, Lensing AW, Piccioli A , et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100 (10) 3484-3488
  • 48 Damascelli B, Ticha V, Patelli G , et al. Use of a retrievable vena cava filter with low-intensity anticoagulation for prevention of pulmonary embolism in patients with cancer: an observational study in 106 cases. J Vasc Interv Radiol 2011; 22 (9) 1312-1319
  • 49 Dewdney SB, Benn T, Rimel BJ , et al. Inferior vena cava filter placement in the gynecologic oncology patient: a 15-year institutional experience. Gynecol Oncol 2011; 121 (2) 344-346
  • 50 Wallace MJ, Jean JL, Gupta S , et al. Use of inferior vena caval filters and survival in patients with malignancy. Cancer 2004; 101 (8) 1902-1907
  • 51 Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000; 216 (1) 54-66
  • 52 Jarrett BP, Dougherty MJ, Calligaro KD. Inferior vena cava filters in malignant disease. J Vasc Surg 2002; 36 (4) 704-707
  • 53 Ghanim AJ, Daskalakis C, Eschelman DJ, Kraft WK. A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. J Thromb Thrombolysis 2007; 24 (3) 247-254
  • 54 Wagman LD, Baird MF, Bennett CL , et al; National Comprehensive Cancer Network. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006; 4 (9) 838-869
  • 55 Lyman GH, Khorana AA, Falanga A , et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25 (34) 5490-5505
  • 56 Major KM, Bulic S, Rowe VL, Patel K, Weaver FA. Internal jugular, subclavian, and axillary deep venous thrombosis and the risk of pulmonary embolism. Vascular 2008; 16 (2) 73-79
  • 57 Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995; 274 (4) 335-337
  • 58 Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997; 111 (3) 661-664
  • 59 Wilasrusmee C, Kiranantawat K, Horsirimanont S , et al. Deep venous thrombosis in surgical intensive care unit: prevalence and risk factors. Asian J Surg 2009; 32 (2) 85-88
  • 60 Murray PT. “Drug dosing in the intensive care unit: the critically ill are a special population too.”. Crit Care Med 2009; 37 (1) 342-343
  • 61 Zagli G, Tarantini F, Bonizzoli M , et al. Altered pharmacology in the intensive care unit patient. Fundam Clin Pharmacol 2008; 22 (5) 493-501
  • 62 Priglinger U, Delle Karth G, Geppert A , et al. Prophylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill?. Crit Care Med 2003; 31 (5) 1405-1409
  • 63 Paton BL, Jacobs DG, Heniford BT, Kercher KW, Zerey M, Sing RF. Nine-year experience with insertion of vena cava filters in the intensive care unit. Am J Surg 2006; 192 (6) 795-800
  • 64 Greenfield LJ, Proctor MC. Vena caval filter use in patients with sepsis: results in 175 patients. Arch Surg 2003; 138 (11) 1245-1248
  • 65 Kaufman JA, Kinney TB, Streiff MB , et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol 2006; 17 (3) 449-459
  • 66 Levy JM, Duszak Jr RL, Akins EW , et al. Inferior vena cava filter placement. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215 (Suppl) 981-997
  • 67 Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg 2007; 31 (1) 98-104
  • 68 Scudday T, Brasel K, Webb T , et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg 2011; 213 (1) 148-153 ; discussion 153–154
  • 69 Koehler DM, Shipman J, Davidson MA, Guillamondegui O. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage. J Trauma 2011; 70 (2) 324-329